Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced details on ...

The complete study cohort includes 1,023 patients from 22 sites in Europe.

Please provide your email address to receive an email when new articles are posted on . Ravulizumab led to maintained control of intravascular hemolysis and sustained stable hemoglobin levels ...

Please provide your email address to receive an email when new articles are posted on . AF ablation with a novel contact force-sensing pulsed field catheter was safe and acutely effective. Three-month ...

This page lists all known medications that could potentially lead to 'Paroxysmal Nocturnal Dyspnea' as a side effect. It's important to note that mild side effects are quite common with medications.

This page lists all known medications that could potentially lead to 'Paroxysmal atrial tachycardia' as a side effect. It's important to note that mild side effects are quite common with medications.

More evidence suggesting that intermittent atrial fibrillation (AF) may be associated with a lower risk for stroke compared with permanent AF has come from a new systematic review of the literature.

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, progressive, multi-system, life-threatening disease, and diagnosing it early in the clinical course is essential for optimizing management ...

VASCULAR collapse is frequently associated with paroxysmal tachycardia. The medical literature consists for the most part of single case reports and reveals that whereas in some cases collapse is ...

PAROXYSMAL nocturnal hemoglobinuria is a rarely recognized cause of hemolytic anemia. Although the exact etiology remains obscure, the erythrocytes develop a defect that sensitizes them to increased ...